½ÃÀ庸°í¼­
»óǰÄÚµå
1763115

¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå º¸°í¼­ : ¿ªÇÐ, ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®, ½ÃÀå ÀλçÀÌÆ® ¹× ¿¹Ãø(2025³â)

Enbrel Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿¥ºê·¼(Enbrel) ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR) 6%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 209¾ï 3,090¸¸ ´Þ·¯·Î ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù. ÀÌ ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº º¹¼öÀÇ ÀûÀÀÁõ¿¡ À־ÀÇ ¿¥ºê·¼ »ç¿ë È®´ë, »ý¹°Á¦Á¦ ¹× ·ù¸¶Æ¼½º °üÀý¿°(ra) Ä¡·á¿¡ ´ëÇÑ Á¤ºÎ Áö¿øÀÇ Áõ°¡, ÀÚ°¡¸é¿ª Áúȯ¿¡ ´ëÇÑ ÀÇ½Ä °íÁ¶, ÀÏ¹Ý Àα¸¿¡¼­ ¿°Áõ¼º Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶, ¹ÙÀÌ¿À½Ã¹Ð·¯ÀÇ ÀÌ¿ë °¡´É¼º Áõ°¡, ¿¥ºê·¼ ÀÎÁö ÃËÁø µî¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÀÚ°¡¸é¿ª Áúȯ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ ÇコÄÉ¾î µµ±¸, Á¦¾à±â¾÷ °£ ¼¼°èÀû ÆÄÆ®³Ê½Ê, ȯÀÚ ÄÄÇöóÀ̾𽺠Çâ»óÀ» À§ÇÑ Àå½Ã°£ ÀÛ¿ëÇü ÁÖ»çÁ¦Á¦ °³¹ß, ÀÚ°¡¸é¿ªÁúȯ Ä¡·á °³¹ß¿¡ ÀÖ¾î ÀΰøÁö´É ÅëÇÕ, »ý¹°Á¦Á¦ ´ëü ¹è´Þ ½Ã½ºÅÛ °³¹ß µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

ÀÚ°¡¸é¿ª ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¿¥ºê·¼(Enbrel) ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÚ°¡¸é¿ª ÁúȯÀº ¸é¿ª°è°¡ ½Ç¼ö·Î ½ÅüÀÇ °Ç°­ÇÑ ¼¼Æ÷³ª Á¶Á÷À» °ø°ÝÇÏ¿© ¿°ÁõÀ̳ª ´Ù¾çÇÑ Àå±â¿¡ ¼Õ»óÀ» ÀÏÀ¸Å°¸é¼­ ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ À¯º´·üÀÇ Áõ°¡´Â À¯ÀüÀû ¼ÒÀÎ, ȯ°æÀû À¯ÀÎ, ¶óÀÌÇÁ½ºÅ¸ÀÏ ¹× ¸é¿ª°è ÇൿÀÇ º¯È­ µîÀÇ ¿äÀΰú °ü·ÃµÇ¾î ÀÖ½À´Ï´Ù. ÀÚ°¡¸é¿ªÁõ·ÊÀÇ Áõ°¡´Â ·ù¸¶Æ¼½º °üÀý¿°À̳ª °Ç¼±¼º °üÀý¿°°ú °°Àº ¿°Áõ¼º ÁúȯÀ» °ü¸®ÇÏ´Â ¿¥ºê·¼°ú °°Àº Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù ±¹¸³ÀÇ·áµµ¼­°üÀº Äڷγª19 ¹é½Å Á¢Á¾°ú °ü·ÃµÈ ÀÚ°¡¸é¿ª Áúȯ »ç·Ê¸¦ ¾à 928·Ê º¸°íÇÏ¿´½À´Ï´Ù. ÀÌ Áß 81.5%(756¿¹)´Â »õ·Î ¹ßº´ÇÑ ÀÚ°¡¸é¿ª ÁúȯÀ¸·Î Áõ»óÀº º¸Åë ¹é½Å Á¢Á¾ ÈÄ 8Àϰ¿¡ ³ªÅ¸³µ½À´Ï´Ù. ¿©¼ºÀº Áõ·ÊÀÇ 53.6%¸¦ Â÷ÁöÇß°í, ¿¬·É Áß¾Ó°ªÀº 48¼¼¿´½À´Ï´Ù. ÀÌó·³ ÀÚ°¡¸é¿ª Áúȯ À¯º´·ü Áõ°¡´Â ¿¥ºê·¼ ½ÃÀåÀ» ÀüÁø½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¥ºê·¼(Enbrel) ½ÃÀåÀÇ Áß¿äÇÑ µ¿ÇâÀº °æÀïÀ» °­È­Çϱâ À§ÇØ ¾à»ç ½ÂÀÎÀ» ¹Þ´Â °ÍÀÔ´Ï´Ù. ÀǾàǰ ½ÂÀÎ °úÁ¤¿¡¼­´Â ±ÔÁ¦ ´ç±¹ÀÌ ÀÓ»ó°Ë»ç µ¥ÀÌÅ͸¦ ±â¹ÝÀ¸·Î ½Å¾àÀÇ ¾ÈÀü¼º, À¯È¿¼º, ǰÁúÀ» Æò°¡ÇÏ°í ½ÂÀÎÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 10¿ù ¹Ì±¹ ¹ÙÀÌ¿ÀÀǾàǰ ȸ»çÀÎ Amgen Inc.´Â Ȱµ¿¼º Á¶±â °Ç¼±¼º °üÀý¿°(JPsA)ÀÇ 2¼¼ ÀÌ»ó ¼Ò¾Æ Ä¡·á¸¦ À§ÇØ ¿£ºê·¼ FDA ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½ÂÀÎÀº ¼ºÀÎÀÇ °üÀý¿°¼º °Ç¼±(PsA), ·ù¸¶Æ¼½º °üÀý¿°(RA), °Ç¼± ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ Æ÷°ýÀûÀÎ ¾ÈÀü¼º ¹× À¯È¿¼º °Ë»ç¸¦ ÅëÇØ ½ÇÁõµÈ Á¾¾ç±«»çÀÎÀÚ Â÷´ÜÁ¦·Î¼­ÀÇ ¿¡Å¸³Ú¼ÁÆ®ÀÇ µ¶Æ¯ÇÑ Æ¯¼ºÀ» °­Á¶ÇÏ´Â °ÍÀÔ´Ï´Ù. ¶ÇÇÑ È°µ¿¼º Á¶±â¼º °üÀý¿°(JIA)°ú °Ç¼± ¼Ò¾Æ ȯÀÚ¿¡¼­ÀÇ »ç¿ëÀ» ÁöÁöÇÏ´Â ¾àÁ¦µ¿ÅÂÇÐÀû(PK) µ¥ÀÌÅ͵µ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. Á¶±â ¹ßº´¼º °üÀý¿°(JPsA)¿¡ ´ëÇÑ ±ÇÀå ¿ë·®Àº üÁß ±â¹ÝÀ̸ç ÁÖ 1ȸ ÇÇÇÏÁÖ»ç·Î Åõ¿©ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀå¿¡¼­ÀÇ Á¦Ç° Ư¼º

  • ºÐÀÚ À¯Çü
  • Åõ¿© °æ·Î(ROA)
  • ÀÛ¿ë±âÀü(MOA)
  • ¾ÈÀü¼º ¹× À¯È¿¼º

Á¦4Àå ½ÃÀå µ¿Çâ ¹× Àü·«

Á¦5Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï ¹× °ü¼¼, Äڷγª¿¬ ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦6Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼® ¹× Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

  • ¼¼°èÀÇ »ó¡: PESTEL ºÐ¼®(Á¤Ä¡, »çȸ, ±â¼ú, ȯ°æ, ¹ýÀû ¿äÀÎ, ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ)
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷ÀÇ ºÐ¼®
  • ¼¼°èÀÇ »ó¡ ½ÃÀå : ¼ºÀå·ü ºÐ¼®
  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå ½ÇÀû : ±Ô¸ð ¹× ¼ºÀå(2019-2024³â)
  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå ¿¹Ãø : ±Ô¸ð ¹× ¼ºÀå(2024-2029³â, 2034³â)
  • ¼¼°èÀÇ »ó¡ : Àüü ½ÃÀå ±Ô¸ð(TAM)

Á¦7Àå ¼¼°èÀÇ °¡°Ý ºÐ¼® ¹× ¿¹Ãø

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå : Á¦Ç°º° ºÐ¼® ¹× ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ÁÖ»ç¾×
  • ÇÁ¸®Çʵå ÁÖ»ç±â
  • º´¿ë ¿ä¹ý
  • ¼­¹æÇü Á¦Á¦
  • ¹ÙÀÌ¿À½Ã¹Ð·¯
  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå : À¯Åë ä³Îº° ºÐ¼® ¹× ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹
  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå : ¿ëµµº° ºÐ¼® ¹× ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ·ù¸¶Æ¼½º °üÀý
  • û¼Ò³â Ư¹ß¼º °üÀý¿°
  • °Ç¼±¼º °üÀý¿°
  • °­Á÷¼º ôÃß¿°
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ÀÓ»óÀûÀÀÁõ ¿ªÇÐ

  • ¾àÁ¦ÀÇ ºÎÀÛ¿ë
  • ÀÓ»óÀûÀÀÁõÀÇ ¹ßº´·ü ¹× À¯º´·ü

Á¦10Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå : Áö¿ªº° ºÐ¼® ¹× ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)
  • ¼¼°èÀÇ ¿¥ºê·¼(Enbrel) ½ÃÀå : ±¹°¡º° ºÐ¼® ¹× ¿¹Ãø(2019-2024³â, 2024-2029³â, 2034³â)

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦12Àå Áß±¹ ½ÃÀå

Á¦13Àå Àεµ ½ÃÀå

Á¦14Àå ÀϺ» ½ÃÀå

Á¦15Àå È£ÁÖ ½ÃÀå

Á¦16Àå Çѱ¹ ½ÃÀå

Á¦17Àå ¼­À¯·´ ½ÃÀå

Á¦18Àå ¿µ±¹ ½ÃÀå

Á¦19Àå µ¶ÀÏ ½ÃÀå

Á¦20Àå ÇÁ¶û½º ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ºÏ¹Ì ½ÃÀå

Á¦23Àå ¹Ì±¹ ½ÃÀå

Á¦24Àå ij³ª´Ù ½ÃÀå

Á¦25Àå ³²¹Ì ½ÃÀå

Á¦26Àå Áßµ¿ ½ÃÀå

Á¦27Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦28Àå °æÀï ±¸µµ ¹× ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ¿¥ºê·¼(Enbrel) ½ÃÀå : °æÀï ±¸µµ
  • ¿¥ºê·¼(Enbrel) ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Amgen Inc.

Á¦29Àå ¼¼°è ½ÃÀå : ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®

Á¦30Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å· ¹× ´ë½Ãº¸µå

Á¦31Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦32Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦33Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹® ¹× Àü·«

  • ¿¥ºê·¼(Enbrel) ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ¿¥ºê·¼(Enbrel) ½ÃÀå(2029³â) : »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ¿¥ºê·¼(Enbrel) ½ÃÀå(2029³â) : ¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ÀÇÇÑ Àü·«
    • °æÀï Àü·«

Á¦34Àå ºÎ·Ï

AJY 25.07.14

Enbrel (generic name: etanercept) is a prescription drug used to manage various autoimmune disorders by suppressing the immune system. This biologic medication functions by blocking tumor necrosis factor (TNF), a substance that contributes to inflammation in conditions like rheumatoid arthritis and psoriasis.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Enbrel is available in several forms, including injectable solutions, prefilled syringes, combination therapies, extended-release formulations, and biosimilars. Injectable solutions are liquid medications administered via injection. These products are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and other related conditions.

The enbrel market research report is one of a series of new reports from The Business Research Company that provides enbrel market statistics, including enbrel industry global market size, regional shares, competitors with a enbrel market share, detailed enbrel market segments, market trends and opportunities, and any further data you may need to thrive in the enbrel industry. This enbrel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enbrel market size is expected to see strong growth in the next few years. It will grow to $20,930.9 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to growing use of enbrel in multiple indications, increasing government support for biologics and rheumatoid arthritis (ra) treatment, growing awareness of autoimmune diseases, rising awareness of inflammatory diseases in the general population, increasing availability of biosimilars, promoting awareness of enbrel. Major trends in the forecast period include digital healthcare tools for managing autoimmune diseases, global partnerships between pharmaceutical companies, development of long-acting injectable formulations for better patient compliance, integration of artificial intelligence in drug development for autoimmune diseases, development of alternative delivery systems for biologic drugs.

The growing prevalence of autoimmune conditions is anticipated to fuel the expansion of the Enbrel market. Autoimmune conditions arise when the immune system erroneously attacks the body's healthy cells and tissues, causing inflammation and damage to various organs. This increasing prevalence is linked to factors such as genetic predisposition, environmental triggers, and lifestyle or immune system behavior changes. The rising number of autoimmune cases boosts the demand for treatments like Enbrel, which manages inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. For example, in August 2022, the National Library of Medicine reported approximately 928 cases of autoimmune conditions associated with COVID-19 vaccination in 2022. Among these, 81.5% (756 cases) were new-onset autoimmune diseases, with symptoms typically appearing eight days post-vaccination. Women accounted for 53.6% of the cases, with a median age of 48. Thus, the growing prevalence of autoimmune conditions is projected to drive the Enbrel market forward.

A significant trend in the Enbrel market involves obtaining regulatory drug approvals to enhance competitive positioning. Drug approval processes involve regulatory authorities assessing and authorizing new drugs for safety, efficacy, and quality based on clinical trial data. For instance, in October 2023, Amgen Inc., a US-based biopharmaceutical company, announced FDA approval for Enbrel to treat children aged two and older with active juvenile psoriatic arthritis (JPsA). This approval underscores the unique attributes of etanercept as a tumor necrosis factor blocker, demonstrated through comprehensive safety and efficacy studies in adults with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and psoriasis. It also includes pharmacokinetic (PK) data supporting its use in pediatric patients with active juvenile idiopathic arthritis (JIA) and psoriasis. The recommended dosage for juvenile PsA (JPsA) is weight-based and administered via weekly subcutaneous injection.

In November 2023, Amazon Web Services Inc. (AWS), a US-based cloud computing company, partnered with Amgen Inc. to enhance production output and expedite global delivery of medications to patients. Through this collaboration, Amgen is utilizing AWS to develop generative AI-based solutions to accelerate the discovery, development, and manufacturing processes for medicines aimed at treating serious illnesses. Amgen Inc. is a US-based producer of Enbrel.

The key copanies operating in the enbrel market is Amgen Inc.

North America was the largest region in the enbrel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enbrel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the enbrel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The enbrel market consists of sales of monoclonal antibodies, cancer immunotherapy drugs and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enbrel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enbrel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enbrel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enbrel market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Injectable Solution; Prefilled Syringes; Combination Therapy; Extended Release Formulations; Biosimilars
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 3) By Application: Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Other Applications
  • Companies Mentioned: Amgen Inc.
  • Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Enbrel Market Characteristics

3. Enbrel Market Biologic Drug Characteristics

  • 3.1. Molecule Type
  • 3.2. Route Of Administration (ROA)
  • 3.3. Mechanism Of Action (MOA)
  • 3.4. Safety And Efficacy

4. Enbrel Market Trends And Strategies

5. Enbrel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Enbrel Growth Analysis And Strategic Analysis Framework

  • 6.1. Global Enbrel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 6.2. Analysis Of End Use Industries
  • 6.3. Global Enbrel Market Growth Rate Analysis
  • 6.4. Global Enbrel Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
  • 6.5. Global Enbrel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
  • 6.6. Global Enbrel Total Addressable Market (TAM)

7. Global Enbrel Pricing Analysis & Forecasts

8. Enbrel Market Segmentation

  • 8.1. Global Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Injectable Solution
  • Prefilled Syringes
  • Combination Therapy
  • Extended Release Formulations
  • Biosimilars
  • 8.2. Global Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 8.3. Global Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Rheumatoid Arthritis
  • Juvenile Idiopathic Arthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Other Applications

9. Global Enbrel Epidemiology Of Clinical Indications

  • 9.1. Drug Side Effects
  • 9.2. Incidence And Prevalence of Clinical Indications

10. Enbrel Market Regional And Country Analysis

  • 10.1. Global Enbrel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 10.2. Global Enbrel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Enbrel Market

  • 11.1. Asia-Pacific Enbrel Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 11.3. Asia-Pacific Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 11.4. Asia-Pacific Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Enbrel Market

  • 12.1. China Enbrel Market Overview
  • 12.2. China Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
  • 12.3. China Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
  • 12.4. China Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Enbrel Market

  • 13.1. India Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 13.2. India Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 13.3. India Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Enbrel Market

  • 14.1. Japan Enbrel Market Overview
  • 14.2. Japan Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 14.3. Japan Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 14.4. Japan Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Enbrel Market

  • 15.1. Australia Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 15.2. Australia Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 15.3. Australia Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Enbrel Market

  • 16.1. South Korea Enbrel Market Overview
  • 16.2. South Korea Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 16.3. South Korea Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 16.4. South Korea Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Enbrel Market

  • 17.1. Western Europe Enbrel Market Overview
  • 17.2. Western Europe Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 17.3. Western Europe Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 17.4. Western Europe Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Enbrel Market

  • 18.1. UK Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 18.2. UK Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 18.3. UK Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Enbrel Market

  • 19.1. Germany Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 19.2. Germany Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 19.3. Germany Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Enbrel Market

  • 20.1. France Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 20.2. France Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 20.3. France Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Enbrel Market

  • 21.1. Eastern Europe Enbrel Market Overview
  • 21.2. Eastern Europe Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 21.3. Eastern Europe Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 21.4. Eastern Europe Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Enbrel Market

  • 22.1. North America Enbrel Market Overview
  • 22.2. North America Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 22.3. North America Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 22.4. North America Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Enbrel Market

  • 23.1. USA Enbrel Market Overview
  • 23.2. USA Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 23.3. USA Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 23.4. USA Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Enbrel Market

  • 24.1. Canada Enbrel Market Overview
  • 24.2. Canada Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 24.3. Canada Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 24.4. Canada Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Enbrel Market

  • 25.1. South America Enbrel Market Overview
  • 25.2. South America Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 25.3. South America Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 25.4. South America Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Enbrel Market

  • 26.1. Middle East Enbrel Market Overview
  • 26.2. Middle East Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 26.3. Middle East Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 26.4. Middle East Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Enbrel Market

  • 27.1. Africa Enbrel Market Overview
  • 27.2. Africa Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 27.3. Africa Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • 27.4. Africa Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Enbrel Market Competitive Landscape And Company Profiles

  • 28.1. Enbrel Market Competitive Landscape
  • 28.2. Enbrel Market Company Profiles
    • 28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Enbrel Market Pipeline Analysis

  • 29.1. High Level Clinic Trail Information

30. Global Enbrel Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Enbrel Market

32. Recent Developments In The Enbrel Market

33. Enbrel Market High Potential Countries, Segments and Strategies

  • 33.1 Enbrel Market In 2029 - Countries Offering Most New Opportunities
  • 33.2 Enbrel Market In 2029 - Segments Offering Most New Opportunities
  • 33.3 Enbrel Market In 2029 - Growth Strategies
    • 33.3.1 Market Trend Based Strategies
    • 33.3.2 Competitor Strategies

34. Appendix

  • 34.1. Abbreviations
  • 34.2. Currencies
  • 34.3. Historic And Forecast Inflation Rates
  • 34.4. Research Inquiries
  • 34.5. The Business Research Company
  • 34.6. Copyright And Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦